Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.090x

Guizhou Bailing Group Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million ≈ $43.13 Million USD) by net assets (CN¥3.28 Billion ≈ $480.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

Cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guizhou Bailing Group Pharmaceutical Co (002424) stock price for real-time trading data and today's change.

Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Guizhou Bailing Group Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002424 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Prodea Real Estate Investment Co. AT:PRODEA	-0.008x
Guan Chong Bhd KLSE:5102	0.188x
Oppenheimer Holdings Inc NYSE:OPY	0.069x
Strait Innovation Internet Co Ltd SHE:300300	-0.104x
Elemental Royalty Corporation NASDAQ:ELE	0.020x
Hotel Shilla KO:008770	-0.137x
Cobram Estate Olives Ltd AU:CBO	-0.028x
Drägerwerk AG & Co. KGaA XETRA:DRW8	0.050x

Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. Review Guizhou Bailing Group Pharmaceutical Co free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.17 Billion ≈ $464.57 Million	CN¥748.72 Million ≈ $109.56 Million	0.236x	+8263.87%
2024-12-31	CN¥3.20 Billion ≈ $468.14 Million	CN¥9.02 Million ≈ $1.32 Million	0.003x	-92.09%
2023-12-31	CN¥3.53 Billion ≈ $516.15 Million	CN¥125.77 Million ≈ $18.40 Million	0.036x	-71.62%
2022-12-31	CN¥4.00 Billion ≈ $584.87 Million	CN¥502.15 Million ≈ $73.48 Million	0.126x	+53.13%
2021-12-31	CN¥3.96 Billion ≈ $579.50 Million	CN¥324.92 Million ≈ $47.55 Million	0.082x	+38.77%
2020-12-31	CN¥3.92 Billion ≈ $573.66 Million	CN¥231.78 Million ≈ $33.92 Million	0.059x	-47.68%
2019-12-31	CN¥4.14 Billion ≈ $605.25 Million	CN¥467.41 Million ≈ $68.40 Million	0.113x	+381.70%
2018-12-31	CN¥3.92 Billion ≈ $574.31 Million	CN¥-157.45 Million ≈ $-23.04 Million	-0.040x	-274.11%
2017-12-31	CN¥3.47 Billion ≈ $507.36 Million	CN¥79.88 Million ≈ $11.69 Million	0.023x	-84.86%
2016-12-31	CN¥3.07 Billion ≈ $448.56 Million	CN¥466.62 Million ≈ $68.28 Million	0.152x	-1.24%
2015-12-31	CN¥2.68 Billion ≈ $392.31 Million	CN¥413.23 Million ≈ $60.47 Million	0.154x	-8.57%
2014-12-31	CN¥2.35 Billion ≈ $343.57 Million	CN¥395.83 Million ≈ $57.92 Million	0.169x	+153.01%
2013-12-31	CN¥2.13 Billion ≈ $311.30 Million	CN¥141.76 Million ≈ $20.74 Million	0.067x	+597.39%
2012-12-31	CN¥2.04 Billion ≈ $298.89 Million	CN¥19.52 Million ≈ $2.86 Million	0.010x	-90.82%
2011-12-31	CN¥1.94 Billion ≈ $283.94 Million	CN¥201.90 Million ≈ $29.54 Million	0.104x	+142.93%
2010-12-31	CN¥1.85 Billion ≈ $270.28 Million	CN¥-447.68 Million ≈ $-65.51 Million	-0.242x	-172.42%
2009-12-31	CN¥374.42 Million ≈ $54.79 Million	CN¥125.31 Million ≈ $18.34 Million	0.335x	+317.54%
2008-12-31	CN¥262.75 Million ≈ $38.45 Million	CN¥-40.42 Million ≈ $-5.92 Million	-0.154x	+64.59%
2007-12-31	CN¥182.68 Million ≈ $26.73 Million	CN¥-79.37 Million ≈ $-11.61 Million	-0.434x	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$908.04 Million

CN¥6.21 Billion CNY

Market Cap Rank

#8960 Global

#2110 in China

Share Price

CN¥4.44

Change (1 day)

-0.89%

52-Week Range

CN¥4.09 - CN¥6.18

All Time High

CN¥28.52